ViaCell is a biotechnology company focused on the area of women’s health.
ViaCell is a biotechnology company focused on the area of women’s health. The company develops ViaCord, which enables families preserve their baby’s umbilical cord blood at the time of birth for possible future medical use; and ViaCyte, to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs.ViaCell is based in Boston, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 14, 2000 | Series Unknown | $48M | 3 | Nomura International | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Nomura International | Yes | Series Unknown |
Sofinov Societe Financiere D'Innovation | — | Series Unknown |
United Offshore Bank Venture Technology Investments | — | Series Unknown |